Doximity earnings release, May 13, 2026

Doximity, Inc. (DOCS) · Form 8-K, Item 2.02 · Filed · SEC filing

Doximity Announces Fourth Quarter and Fiscal Year 2026 Financial Results

Fiscal year 2026 total revenues of $644.9 million, up 13% year-over-year

Fiscal year 2026 operating cash flows of $326.5 million, up 19% year-over-year

Fiscal year 2026 free cash flow of $317.5 million, up 19% year-over-year

SAN FRANCISCO, Calif., May 13, 2026

-- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 fourth quarter and fiscal year ended March 31, 2026.

“We’re thrilled to announce that we reached a new engagement record of over 800,000 active prescribers using our workflow tools in Q4. Nearly half of those providers used our clinical AI last quarter, while our prompts per user nearly doubled from January to April alone,” said Jeff Tangney, co-founder and CEO of Doximity.

“Our new partnerships with Aledade and Photon build on that momentum, bringing our Clinical AI Suite to thousands of independent practices and enabling seamless in-workflow prescribing for the first time. I'm also thrilled to welcome Matt Sonefeldt as our new CFO and Dr. Steve Zatz as our new President, two exceptional leaders whose experience and relationships will be instrumental as we continue to scale.”

Fiscal 2026 Fourth Quarter Financial Highlights

All comparisons, unless otherwise noted, are to the three months ended March 31, 2025.

• Revenue:

Revenue of $145.4 million, versus $138.3 million, an increase of 5% year-over-year.

• Net income and non-GAAP net income:

Net income of $19.1 million, versus $62.5 million, representing a margin of 13.1%, versus 45.2%. Non-GAAP net income of $49.8 million, versus $77.7 million, representing a margin of 34.2%, versus 56.2%.

• Adjusted EBITDA:

Adjusted EBITDA of $65.8 million, versus $69.7 million, a decrease of 6% year-over-year, representing adjusted EBITDA margins of 45.3%, versus 50.4%.

• Diluted net income per share and non-GAAP diluted net income per share:

Diluted net income per share was $0.10, versus $0.31, while non-GAAP diluted net income per share was $0.26, versus $0.38.

• Operating cash flow and free cash flow

: Operating cash flow of $109.5 million, versus $98.5 million, an increase of 11% year-over-year, and free cash flow of $107.3 million, versus $97.0 million, an increase of 11% year-over-year.

Fiscal Year

2026 Financial Highlights

All comparisons, unless otherwise noted, are to the fiscal year ended March 31, 2025.

• Revenue:

Revenue of $644.9 million, versus $570.4 million, an increase of 13% year-over-year.

• Net income and non-GAAP net income:

Net income of $196.1 million, versus $223.2 million, representing a margin of 30.4%, versus 39.1%. Non-GAAP net income of $302.7 million, versus $286.1 million, representing a margin of 46.9%, versus 50.2%.

• Adjusted EBITDA:

Adjusted EBITDA of $357.8 million, versus $313.8 million, an increase of 14%, representing adjusted EBITDA margins of 55.5%, versus 55.0%.

• Diluted net income per share and non-GAAP diluted net income per share:

Diluted net income per share was $0.98, versus $1.11, while non-GAAP diluted net income per share was $1.52, versus $1.42.

• Operating cash flow and free cash flow

: Operating cash flow of $326.5 million, versus $273.3 million, an increase of 19% year-over-year, and free cash flow of $317.5 million, versus $266.7 million, an increase of 19% year-over-year.¹

Financial Outlook

Doximity is providing guidance for its fiscal first quarter ending June 30, 2026 as follows:

• Revenue between $151 million and $152 million.

• Adjusted EBITDA between $68.5 million and $69.5 million.

Doximity is providing guidance for its fiscal year ending March 31, 2027 as follows:

• Revenue between $664 million and $676 million.

• Adjusted EBITDA between $323 million and $335 million.²

Conference Call Information

Doximity posted prepared remarks on its investor relations website at https://investors.doximity.com. Doximity will host a webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these financial results. To listen to a live audio webcast, please visit the Company’s Investor Relations page at https://investors.doximity.com. The archived webcast will be available on the Company’s Investor Relations page shortly after the call.

About Doximity

Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 85% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay current on medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. With new AI-powered clinical reference and search capabilities, Doximity also helps doctors access trusted, peer-reviewed information and medical literature. Doximity's mission is to help doctors be more productive so they can provide better care for their patients.

Financial statements

Income Statement

Three Months Ended March 31, — (unaudited)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025Fiscal Year Ended March 31, – 2026Fiscal Year Ended March 31, – 2025
Revenue145,372138,288644,863570,399
Cost of revenue(1)19,40714,46770,32655,874
Gross profit125,965123,821574,537514,525
Operating expenses(1):Research and development39,10624,803130,70293,038
Operating expenses(1):Sales and marketing45,91037,611163,648145,713
Operating expenses(1):General and administrative16,12312,72765,26745,670
Operating expenses(1):Impairment charge2,304
Operating expenses(1):Total operating expenses101,13975,141359,617286,725
Operating expenses(1):Income from operations24,82648,680214,920227,800
Operating expenses(1):Other income, net7,2959,71435,08535,774
Operating expenses(1):Income before income taxes32,12158,394250,005263,574
Operating expenses(1):Provision for (benefit from) income taxes13,007-4,06453,95440,389
Operating expenses(1):Net income19,11462,458196,051223,185
Net income per share attributable to Class A and Class B common stockholders:Basic0.10.331.051.19
Net income per share attributable to Class A and Class B common stockholders:Diluted0.10.310.981.11
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:Basic184,852188,362187,014186,841
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:Diluted195,026202,987199,048201,208

Income Statement

Three Months Ended March 31, — (1) Cost of revenue and operating expenses include stock-based compensation expense as follows (in thousands):

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025Fiscal Year Ended March 31, – 2026Fiscal Year Ended March 31, – 2025
Cost of revenue2,9572,62811,68011,001
Research and development15,9944,79246,15919,394
Sales and marketing11,2536,44239,39726,323
General and administrative6,5384,19824,39115,668
Total stock-based compensation expense36,74218,060121,62772,386

Income Statement

Three Months Ended March 31, — The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below: (in thousands)

Three Months Ended March 31, – 2026 – (unaudited)Three Months Ended March 31, – 2025 – (unaudited)Fiscal Year Ended March 31, – 2026 – (unaudited)Fiscal Year Ended March 31, – 2025 – (unaudited)
Net income19,11462,458196,051223,185
Adjusted to exclude the following:Acquisition and other related expenses1,616
Adjusted to exclude the following:Stock-based compensation36,74218,060121,62772,386
Adjusted to exclude the following:Depreciation and amortization4,1312,82914,38310,659
Adjusted to exclude the following:Provision for (benefit from) income taxes13,007-4,06453,95440,389
Adjusted to exclude the following:Impairment charge2,304
Adjusted to exclude the following:Change in fair value of contingent earn-out consideration liability79167417680
Adjusted to exclude the following:Legal expenses404,853
Adjusted to exclude the following:Other income, net-7,295-9,714-35,085-35,774
Adjusted to exclude the following:Adjusted EBITDA65,81869,736357,816313,829
Adjusted to exclude the following:Revenue145,372138,288644,863570,399
Adjusted to exclude the following:Net income margin13.145.230.439.1
Adjusted to exclude the following:Adjusted EBITDA margin45.350.455.555

Income Statement

Three Months Ended March 31, — The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below: (in thousands)

Three Months Ended March 31, – 2026 – (unaudited)Three Months Ended March 31, – 2025 – (unaudited)Fiscal Year Ended March 31, – 2026 – (unaudited)Fiscal Year Ended March 31, – 2025 – (unaudited)
GAAP cost of revenue19,40714,46770,32655,874
Adjusted to exclude the following:Stock-based compensation-2,957-2,628-11,680-11,001
Adjusted to exclude the following:Amortization of acquired intangibles-935-935
Adjusted to exclude the following:Non-GAAP cost of revenue15,51511,83957,71144,873
Adjusted to exclude the following:GAAP gross profit125,965123,821574,537514,525
Adjusted to exclude the following:Stock-based compensation2,9572,62811,68011,001
Adjusted to exclude the following:Amortization of acquired intangibles935935
Adjusted to exclude the following:Non-GAAP gross profit129,857126,449587,152525,526
Adjusted to exclude the following:GAAP gross margin86.789.589.1%90.2
Adjusted to exclude the following:Non-GAAP gross margin89.391.491.1%92.1
Adjusted to exclude the following:GAAP research and development expense39,10624,803130,70293,038
Adjusted to exclude the following:Stock-based compensation-15,994-4,792-46,159-19,394
Adjusted to exclude the following:Amortization of acquired intangibles-1,558
Adjusted to exclude the following:Non-GAAP research and development expense23,11220,01182,98573,644
Adjusted to exclude the following:GAAP sales and marketing expense45,91037,611163,648145,713
Adjusted to exclude the following:Stock-based compensation-11,253-6,442-39,397-26,323

Income Statement

Three Months Ended March 31, — The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below: (in thousands)

Three Months Ended March 31, – 2026 – (unaudited)Three Months Ended March 31, – 2025 – (unaudited)Fiscal Year Ended March 31, – 2026 – (unaudited)Fiscal Year Ended March 31, – 2025 – (unaudited)
GAAP operating expense101,13975,141359,617286,725
Adjusted to exclude the following:Acquisition and other related expenses-1,616
Adjusted to exclude the following:Stock-based compensation-33,785-15,432-109,947-61,385
Adjusted to exclude the following:Amortization of acquired intangibles-1,005-1,061-5,572-4,244
Adjusted to exclude the following:Change in fair value of contingent earn-out consideration liability-79-167-417-680
Adjusted to exclude the following:Legal expenses-40-4,853
Adjusted to exclude the following:Impairment charge-2,304
Adjusted to exclude the following:Non-GAAP operating expense66,23058,481237,212218,112
Adjusted to exclude the following:GAAP operating income24,82648,680214,920227,800
Adjusted to exclude the following:Acquisition and other related expenses1,616
Adjusted to exclude the following:Stock-based compensation36,74218,060121,62772,386
Adjusted to exclude the following:Amortization of acquired intangibles1,9401,0616,5074,244
Adjusted to exclude the following:Change in fair value of contingent earn-out consideration liability79167417680
Adjusted to exclude the following:Legal expenses404,853
Adjusted to exclude the following:Impairment charge2,304
Adjusted to exclude the following:Non-GAAP operating income63,62767,968349,940307,414
Adjusted to exclude the following:GAAP net income19,11462,458196,051223,185
Adjusted to exclude the following:Acquisition and other related expenses1,616
Adjusted to exclude the following:Stock-based compensation36,74218,060121,62772,386
Adjusted to exclude the following:Amortization of acquired intangibles1,9401,0616,5074,244
Adjusted to exclude the following:Change in fair value of contingent earn-out consideration liability79167417680
Adjusted to exclude the following:Legal expenses404,853
Adjusted to exclude the following:Impairment charge2,304
Adjusted to exclude the following:Income tax effect of non-GAAP adjustments (1)-8,148-4,050-28,354-16,719
Adjusted to exclude the following:Non-GAAP net income49,76777,696302,717286,080
Adjusted to exclude the following:Non-GAAP net income margin34.256.246.950.2
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:Basic184,852188,362187,014186,841
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:Diluted195,026202,987199,048201,208
Non-GAAP net income per share attributable to Class A and Class B stockholders:Basic0.270.411.621.53
Non-GAAP net income per share attributable to Class A and Class B stockholders:Diluted0.260.381.521.42

Balance Sheet

March 31, 2026 — (unaudited)

March 31, 2026March 31, 2025
Current assets:Cash and cash equivalents219,178209,614
Current assets:Marketable securities529,423706,050
Current assets:Accounts receivable, net144,783128,354
Current assets:Prepaid expenses and other current assets50,88044,602
Current assets:Total current assets944,2641,088,620
Current assets:Property and equipment, net18,08013,656
Current assets:Deferred income tax assets31,98460,014
Current assets:Operating lease right-of-use assets7,1408,886
Current assets:Intangible assets, net35,32523,072
Current assets:Goodwill84,97367,940
Current assets:Other assets1,9212,121
Current assets:Total assets1,123,6871,264,309
Current liabilities:Accounts payable4,0091,356
Current liabilities:Accrued expenses and other current liabilities42,80438,405
Current liabilities:Deferred revenue, current106,050114,285
Current liabilities:Operating lease liabilities, current2,1102,211
Current liabilities:Total current liabilities154,973156,257
Current liabilities:Deferred revenue, non-current400280
Current liabilities:Operating lease liabilities, non-current8,07510,185
Current liabilities:Contingent earn-out consideration liability, non-current5,579
Current liabilities:Other liabilities, non-current9,4029,383
Current liabilities:Total liabilities172,850181,684
Stockholders' EquityCommon stock183189
Stockholders' EquityAdditional paid-in capital1,001,688894,225

Cash Flow

Three Months Ended March 31, — (unaudited)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025Fiscal Year Ended March 31, – 2026Fiscal Year Ended March 31, – 2025
Cash flows from operating activitiesNet income19,11462,458196,051223,185
Adjustments to reconcile net income to net cash provided by operating activities:Depreciation and amortization4,1312,82914,38310,659
Adjustments to reconcile net income to net cash provided by operating activities:Deferred income taxes32,138-13,78832,138-11,592
Adjustments to reconcile net income to net cash provided by operating activities:Stock-based compensation, net of amounts capitalized36,74218,060121,62772,386
Adjustments to reconcile net income to net cash provided by operating activities:Non-cash lease expense3844461,7471,838
Adjustments to reconcile net income to net cash provided by operating activities:Accretion of discount on marketable securities, net-1,130-2,919-7,581-11,655
Adjustments to reconcile net income to net cash provided by operating activities:Amortization of deferred contract costs4,2073,42313,4789,967
Adjustments to reconcile net income to net cash provided by operating activities:Impairment of long-lived assets2,304
Adjustments to reconcile net income to net cash provided by operating activities:Other133-19314270
Changes in operating assets and liabilities:Accounts receivable11,7209,258-16,879-27,206
Changes in operating assets and liabilities:Prepaid expenses and other assets1,105-18,489-8,2722,762
Changes in operating assets and liabilities:Deferred contract costs-3,231-2,982-14,490-12,051
Changes in operating assets and liabilities:Accounts payable, accrued expenses and other liabilities-35,254-4,5354,268-663
Changes in operating assets and liabilities:Deferred revenue39,96945,295-8,11515,210
Changes in operating assets and liabilities:Operating lease liabilities-506-550-2,211-2,149
Changes in operating assets and liabilities:Net cash provided by operating activities109,52298,487326,458273,265
Cash flows from investing activitiesCash paid for acquisition-26,528
Cash flows from investing activitiesPurchases of intangible assets-62
Cash flows from investing activitiesInternal-use software development costs-2,253-1,507-8,901-6,525
Cash flows from investing activitiesPurchases of marketable securities-8,037-143,724-389,159-675,557
Cash flows from investing activitiesMaturities of marketable securities148,267118,180561,434635,401
Cash flows from investing activitiesSales of marketable securities2,57810,38617,383
Cash flows from investing activitiesNet cash provided by (used in) investing activities137,977-24,473147,170-29,298
Cash flows from financing activitiesProceeds from issuance of common stock upon exercise of stock options and common stock warrants2,7675,8279,78419,732
Cash flows from financing activitiesProceeds from issuance of common stock in connection with the employee stock purchase plan2,0762,1473,8923,569
Cash flows from financing activitiesTaxes paid related to net share settlement of equity awards-7,477-10,856-40,839-27,185
Cash flows from financing activitiesRepurchase of common stock-90,525-26,788-431,652-120,293
Cash flows from financing activitiesPayment of contingent consideration related to a business combination-5,249-5,470
Cash flows from financing activitiesPayment of excise taxes on share repurchases-1,491
Cash flows from financing activitiesNet cash used in financing activities-93,159-29,670-464,064-131,138
Cash flows from financing activitiesNet increase in cash and cash equivalents154,34044,3449,564112,829
Cash flows from financing activitiesCash and cash equivalents, beginning of period64,838165,270209,61496,785
Cash flows from financing activitiesCash and cash equivalents, end of period219,178209,614219,178209,614
Supplemental disclosures of cash flow informationCash paid for taxes, net of refunds79219,84021,81455,654

Cash Flow

Three Months Ended March 31, — The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below: (in thousands)

Three Months Ended March 31, – 2026 – (unaudited)Three Months Ended March 31, – 2025 – (unaudited)Fiscal Year Ended March 31, – 2026 – (unaudited)Fiscal Year Ended March 31, – 2025 – (unaudited)
Net cash provided by operating activities109,52298,487326,458273,265
Purchases of intangible assets-62
Internal-use software development costs-2,253-1,507-8,901-6,525
Free cash flow107,26996,980317,495266,740
Other cash flow components:Net cash provided by (used in) investing activities137,977-24,473147,170-29,298
Other cash flow components:Net cash used in financing activities-93,159-29,670-464,064-131,138
Full release

Forward-Looking Statements... (truncated)tegies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations, or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors including (i) the timing and scope of anticipated stock repurchases; (ii) the impact of uncertainty in the current economic environment and macroeconomic uncertainty; (iii) our ability to retain existing members or add new members to our platform and maintain or grow their engagement with our platform; (iv) our ability to attract new customers or retain existing customers; (v) the impact of our prioritization of our members’ interests; (vi) breaches in our security measures or unauthorized access to members’ data; (vii) our ability to maintain or manage our growth, and other risks and factors that are beyond our control including, without limitation, those set forth in the section entitled “Risk Factors” in the Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2025. Additional information will be provided in our Annual Report on Form 10-K for the fiscal year ended March 31, 2026. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could cause actual results to differ materially from those contained in our forward-looking statements. The forward-looking statements made in this press release relate only to management’s beliefs and assumptions as of this date. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Investor Relations Contact:

Perry Gold ir@doximity.com

Media Contact:

Amanda Cox pr@doximity.com³

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Doximity earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.